ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

House committee Seeks $239 Million Cut In Clinton’s NIH Budget

March 11, 1994

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Guttmacher Named NICHD Director

December 18, 2009

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980